Impact of Vendor Systems on Ambulatory Medication Safety (BWHCERT5E)

This study has been completed.
Sponsor:
Collaborator:
Information provided by (Responsible Party):
Weill Medical College of Cornell University
ClinicalTrials.gov Identifier:
NCT00773500
First received: October 3, 2008
Last updated: February 27, 2012
Last verified: February 2012
  Purpose

Our objective is to determine the effects of electronic prescribing on medication safety including medication errors, near misses and preventable adverse drug events in the ambulatory setting. Study design will be a longitudinal evaluation of errors early after implementation and after sustained use.


Condition Intervention
Medication Errors
Other: Electronic prescribing

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Impact of Vendor Systems on Ambulatory Medication Safety

Resource links provided by NLM:


Further study details as provided by Weill Medical College of Cornell University:

Primary Outcome Measures:
  • prescribing error [ Time Frame: 1 year ] [ Designated as safety issue: Yes ]

Secondary Outcome Measures:
  • near misses [ Time Frame: 1 year ] [ Designated as safety issue: Yes ]
  • preventable adverse drug events [ Time Frame: 1 year ] [ Designated as safety issue: Yes ]

Enrollment: 20
Study Start Date: September 2008
Study Completion Date: October 2011
Primary Completion Date: July 2011 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
1
Providers adopting electronic prescribing in New York City, New York
Other: Electronic prescribing
Implementation of a commercially available electronic prescribing system with clinical decision support
2
Providers adopting electronic prescribing in the Taconic region of New York
Other: Electronic prescribing
Implementation of a commercially available electronic prescribing system with clinical decision support

Detailed Description:

We will compare the effects of different vendor-based electronic prescribing systems on ambulatory medication safety in various settings, including rural and underserved areas and determine the effects of electronic prescribing systems on ambulatory medication safety over time.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

Our study will take place in 2 NYS communities. We will select 2 communities in order to assemble a study population with the following characteristics: use of at least 2 different vendor-based systems, different implementation times (with some communities being early adopters and others experienced users), and inclusion of urban underserved and federally defined rural areas.

We will select the following 2 communities/organizations: the community health centers implementing electronic prescribing with the New York City Department of Health (NYC DOH) and the Taconic Health Information Network and Community (THINC) in the Hudson Valley of New York. Both communities have expressed their interest in participating in this study.

Criteria

Inclusion Criteria:

  • >=0.75 FTE providers

Exclusion Criteria:

  • <0.75 FTE providers
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00773500

Locations
United States, New York
Taconic IPA
Fishkill, New York, United States, 12524
New York City Department of Health and Mental Hygiene
New York, New York, United States, 10038
Sponsors and Collaborators
Weill Medical College of Cornell University
Investigators
Principal Investigator: Rainu Kaushal, MD, MPH Weill Medical College of Cornell University
  More Information

No publications provided by Weill Medical College of Cornell University

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Weill Medical College of Cornell University
ClinicalTrials.gov Identifier: NCT00773500     History of Changes
Other Study ID Numbers: U18HS0169705E
Study First Received: October 3, 2008
Last Updated: February 27, 2012
Health Authority: United States: Institutional Review Board

Keywords provided by Weill Medical College of Cornell University:
Medication Errors

ClinicalTrials.gov processed this record on July 10, 2014